IXICO plc Total Voting Rights (2665E)

TIDMIXI

RNS Number : 2665E

IXICO plc

02 November 2015

2 November 2015

IXICO plc

Total Voting Rights

In accordance with the requirements of the FCA's Disclosure and Transparency Rule 5.6.1, IXICO plc (Ticker: IXI) ('IXICO' or the 'Company') confirms that the Company's issued share capital consists of 15,215,664 ordinary shares of 50p each in issue, each with equal voting rights. No shares are held in treasury.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure and Transparency Rules.

Enquiries:

 
 IXICO plc                                       +44 20 3763 7499 
 Derek Hill, CEO 
 Susan Lowther, CFO 
 Charles Spicer, VP Corporate Development 
 
 Peel Hunt LLP (Nominated Adviser and Broker)    +44 20 7418 8900 
 James Steel 
 Oliver Jackson 
 
 Daniel Stewart & Company (Joint Broker)         +44 207 776 6550 
 Martin Lampshire 
 David Coffman 
 
 FTI Consulting Limited (Investor Relations)     +44 20 3727 1000 
 Simon Conway 
 Mo Noonan 
 Matthew Moss

Notes to Editors

About IXICO

IXICO, the brain health company, uses its innovative and proprietary digital platform technologies to help those involved in researching and treating serious diseases to make rapid, informed decisions targeted at improving patient outcomes. IXICO has significant experience working with global pharmaceutical and biotechnology companies supporting clinical studies in the field of neuro-degenerative disorders including dementia, Alzheimer's disease, Huntington's disease and Multiple Sclerosis.

More information is available on www.ixico.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

TVRUGGMWGUPAGAP

(END) Dow Jones Newswires

November 02, 2015 10:38 ET (15:38 GMT)

Phytopharm (LSE:PYM)
過去株価チャート
から 11 2024 まで 12 2024